XML 55 R42.htm IDEA: XBRL DOCUMENT
v3.25.1

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables) | 12 Months Ended
--- | ---
Mar. 29, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule of Interest Rate Derivatives | The Company held the following interest rate swaps as of March 29, 2025:
Hedged Item |  | Original Notional Amount |  | Notional Amount as of March 29, 2025 |  | Designation Date |  | Effective Date |  | Termination Date |  | Fixed Interest Rate |  | Estimated Fair Value Assets (Liabilities)
(In thousands) |  |  |  |  |  |  |  |  |  |  |  |  |  |
1-month USD Term SOFR |  | $ | 109,900 |  |  | $ | 102,944 |  |  | 9/27/2024 |  | 9/30/2024 |  | 4/30/2029 |  | 3.32% |  | $ | 1,076 |
1-month USD Term SOFR |  | 109,900 |  |  | 101,553 |  |  | 9/27/2024 |  | 9/30/2024 |  | 4/30/2029 |  | 3.30% |  | 1,250 |
Total |  | $ | 219,800 |  |  | $ | 204,497 |  |  |  |  |  |  |  |  |  |  | $ | 2,326 |
Accounts Receivable, Allowance for Credit Loss | The following is a roll forward of the allowance for credit losses:
|  | Twelve Months Ended
(In thousands) |  | March 29, 2025 |  | March 30, 2024 |  | April 1, 2023
Beginning balance |  | $ | 5,695 |  |  | $ | 4,932 |  |  | $ | 2,475 |
Credit loss |  | 725 |  |  | 840 |  |  | 2,623 |
Recoveries |  | (120) |  |  | (77) |  |  | (166) |
Ending balance |  | $ | 6,300 |  |  | $ | 5,695 |  |  | $ | 4,932 |
Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments | The following table presents the effect of the Company’s derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its consolidated statements of income and comprehensive income for the fiscal year ended March 29, 2025.
Derivative Instruments |  | Amount of (Loss) Gain Recognized in Accumulated Other Comprehensive Loss |  | Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings |  | Location in Consolidated Statements of Income and Comprehensive Income |  | Amount of Gain Excluded from Effectiveness Testing |  | Location in Consolidated Statements of Income and Comprehensive Income
(In thousands) |  |  |  |  |  |  |  |  |  |
Designated foreign currency hedge contracts, net of tax |  | $ | (1,508) |  |  | $ | 11 |  |  | Net revenues, COGS and SG&A |  | $ | 1,743 |  |  | Interest and other expense, net
Non-designated foreign currency hedge contracts |  | $ | — |  |  | $ | — |  |  |  |  | $ | (1,534) |  |  | Interest and other expense, net
Designated interest rate swaps, net of tax |  | $ | 573 |  |  | $ | (67) |  |  | Interest and other expense, net |  | $ | — |  |  |
Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets | The following tables present the fair value of the Company’s derivative instruments as they appear in its consolidated balance sheets as of March 29, 2025 and March 30, 2024:
(In thousands) | Location in Consolidated Balance Sheet |  | As of March 29, 2025 |  | As of March 30, 2024
Derivative Assets: |  |  |  |  |
Designated foreign currency hedge contracts | Prepaid expenses and other current assets |  | $ | 193 |  |  | $ | 1,353 |
Non-designated foreign currency hedge contracts | Other current assets |  | 85 |  |  | 154 |
Designated interest rate swaps | Other current assets |  | 1,305 |  |  | 1,673 |
Designated interest rate swaps | Other long-term assets |  | 1,020 |  |  | 62 |
|  |  | $ | 2,603 |  |  | $ | 3,242 |
Derivative Liabilities: |  |  |  |  |
Designated foreign currency hedge contracts | Other current liabilities |  | $ | 471 |  |  | $ | 395 |
Non-designated foreign currency hedge contracts | Other current liabilities |  | 25 |  |  | 536 |
|  |  | $ | 496 |  |  | $ | 931 |
Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis | Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of March 29, 2025 and March 30, 2024.
|  | As of March 29, 2025
(In thousands) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |
Money market funds |  | $ | 158,916 |  |  | $ | — |  |  | $ | — |  |  | $ | 158,916 |
Designated foreign currency hedge contracts |  | — |  |  | 193 |  |  | — |  |  | 193 |
Non-designated foreign currency hedge contracts |  | — |  |  | 85 |  |  | — |  |  | 85 |
Designated interest rate swaps |  | — |  |  | 2,325 |  |  | — |  |  | 2,325 |
|  | $ | 158,916 |  |  | $ | 2,603 |  |  | $ | — |  |  | $ | 161,519 |
Liabilities |  |  |  |  |  |  |  |
Designated foreign currency hedge contracts |  | $ | — |  |  | $ | 471 |  |  | $ | — |  |  | $ | 471 |
Non-designated foreign currency hedge contracts |  | — |  |  | 25 |  |  | — |  |  | 25 |
Contingent consideration |  | — |  |  | — |  |  | 2,278 |  |  | 2,278 |
|  | $ | — |  |  | $ | 496 |  |  | $ | 2,278 |  |  | $ | 2,774 |
|  | As of March 30, 2024
|  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |  |
Money market funds |  | $ | 43,073 |  |  | $ | — |  |  | $ | — |  |  | $ | 43,073 |
Designated foreign currency hedge contracts |  | — |  |  | 1,353 |  |  | — |  |  | 1,353 |
Non-designated foreign currency hedge contracts |  | — |  |  | 154 |  |  | — |  |  | 154 |
Designated interest rate swaps |  | — |  |  | 1,735 |  |  | — |  |  | 1,735 |
|  | $ | 43,073 |  |  | $ | 3,242 |  |  | $ | — |  |  | $ | 46,315 |
Liabilities |  |  |  |  |  |  |  |
Designated foreign currency hedge contracts |  | $ | — |  |  | $ | 395 |  |  | $ | — |  |  | $ | 395 |
Non-designated foreign currency hedge contracts |  | — |  |  | 536 |  |  | — |  |  | 536 |
|  | $ | — |  |  | $ | 931 |  |  | $ | — |  |  | $ | 931 |
The level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:
|  | Fair Value at |  | Valuation |  | Unobservable |  |
(In thousands) |  | March 29, 2025 |  | Technique |  | Input |  | Range
Revenue-based payments |  | $ | 1,214 |  |  | Monte Carlo Simulation Model |  | Discount rate |  | 6.3%
|  |  | Projected fiscal year of payments |  | 2026 - 2028
Regulatory-based payment |  | $ | — |  |  | Monte Carlo Simulation Model |  | Discount rate |  | N/A
|  |  | Probability of payment |  | 0%
|  |  | Projected fiscal year of payment |  | N/A
Event-based payment |  | $ | 1,064 |  |  | Monte Carlo Simulation Model |  | Discount rate |  | 5.8%
|  |  | Projected fiscal year of payment |  | 2026 - 2028
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | The fair value of contingent consideration associated with acquisitions was $2.3 million at March 29, 2025 and the total was included in Other long-term liabilities. A reconciliation of the change in the fair value of contingent consideration is included in the following table:
(In thousands) |  |
Balance at March 30, 2024 |  | $ | — |
Acquisition date fair value of contingent consideration |  | 25,000 |
Purchase accounting adjustments |  | 300 |
Change in fair value |  | (23,022) |
Balance at March 29, 2025 |  | $ | 2,278 |

X
- Definition Tabular disclosure of allowance for credit loss on accounts receivable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13 + Details
Name: | us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C + Details
Name: | us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration